BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7528778)

  • 1. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
    Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
    J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR; Neame SJ; Isacke CM
    Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
    Lokeshwar VB; Fregien N; Bourguignon LY
    J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
    Lesley J; English N; Perschl A; Gregoroff J; Hyman R
    J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
    Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
    J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
    Dougherty GJ; Cooper DL; Memory JF; Chiu RK
    J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
    He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
    J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system.
    Aho R; Jalkanen S; Kalimo H
    J Neuropathol Exp Neurol; 1994 May; 53(3):295-302. PubMed ID: 7513749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.
    van der Voort R; Manten-Horst E; Smit L; Ostermann E; van den Berg F; Pals ST
    Biochem Biophys Res Commun; 1995 Sep; 214(1):137-44. PubMed ID: 7545390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion.
    Siegelman MH; Stanescu D; Estess P
    J Clin Invest; 2000 Mar; 105(5):683-91. PubMed ID: 10712440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
    Yang B; Yang BL; Savani RC; Turley EA
    EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
    Zheng Z; Katoh S; He Q; Oritani K; Miyake K; Lesley J; Hyman R; Hamik A; Parkhouse RM; Farr AG; Kincade PW
    J Cell Biol; 1995 Jul; 130(2):485-95. PubMed ID: 7542251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response.
    Lesley J; Howes N; Perschl A; Hyman R
    J Exp Med; 1994 Jul; 180(1):383-7. PubMed ID: 7516415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate.
    Wu L; Kincade PW; Shortman K
    Immunol Lett; 1993 Sep; 38(1):69-75. PubMed ID: 7507884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.